{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "currency": "EUR", "market": "dr_market", "esgPopulated": false, "gmtOffSetMilliseconds": 7200000, "exchange": "FRA", "longName": "NightHawk Biosciences, Inc.", "shortName": "NIGHTHAWK BIOSC. DL-,0002", "regularMarketPrice": 0.625, "regularMarketChangePercent": 0.80645084, "messageBoardId": "finmb_79723070", "marketState": "REGULAR", "fiftyTwoWeekHighChangePercent": -0.7892785, "fiftyTwoWeekLow": 0.595, "fiftyTwoWeekHigh": 2.966, "earningsTimestamp": 1680293100, "earningsTimestampStart": 1684148340, "earningsTimestampEnd": 1684497600, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "fiftyTwoWeekLowChange": 0.029999971, "fiftyTwoWeekLowChangePercent": 0.050420117, "fiftyTwoWeekRange": "0.595 - 2.966", "fiftyTwoWeekHighChange": -2.341, "epsTrailingTwelveMonths": -1.6, "epsForward": -1.22, "epsCurrentYear": -1.18, "priceEpsCurrentYear": -0.52966106, "sharesOutstanding": 26049200, "bookValue": 2.881, "fiftyDayAverage": 0.75692, "fiftyDayAverageChange": -0.13191998, "fiftyDayAverageChangePercent": -0.17428523, "twoHundredDayAverage": 1.320743, "twoHundredDayAverageChange": -0.69574296, "twoHundredDayAverageChangePercent": -0.5267815, "marketCap": 17040376, "forwardPE": -0.51229507, "priceToBook": 0.21693856, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "prevName": "Heat Biologics, Inc.", "nameChangeDate": "2023-05-11", "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1375250400000, "priceHint": 4, "regularMarketChange": 0.004999995, "regularMarketTime": 1683871295, "regularMarketDayHigh": 0.625, "regularMarketDayRange": "0.625 - 0.625", "regularMarketDayLow": 0.625, "regularMarketVolume": 4000, "regularMarketPreviousClose": 0.62, "bid": 0.605, "ask": 0.625, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 0.625, "averageDailyVolume3Month": 188, "averageDailyVolume10Day": 0, "symbol": "1HB.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "627 Davis Drive", "address2": "Suite 300", "city": "Morrisville", "state": "NC", "zip": "27560", "country": "United States", "phone": "919 240 7133", "website": "https://www.nighthawkbio.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "NightHawk Biosciences, Inc., an integrated biopharmaceutical company, develops, manufactures, and commercializes medical countermeasures that combat unmet and emerging biothreats. The company develops ANTHIM (obiltoxaximab), a monoclonal antibody antitoxin for the treatment of inhalational anthrax. The company was formerly known as Heat Biologics, Inc. and changed its name to NightHawk Biosciences, Inc. in May 2022. NightHawk Biosciences, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.", "fullTimeEmployees": 77, "companyOfficers": [{"maxAge": 1, "name": "Mr. Jeffrey Alan Wolf J.D.", "age": 59, "title": "Founder, Chairman, CEO & Pres", "yearBorn": 1963, "fiscalYear": 2022, "totalPay": {"raw": 842600, "fmt": "842.6k", "longFmt": "842,600"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 16738, "fmt": "16.74k", "longFmt": "16,738"}}, {"maxAge": 1, "name": "Mr. William L. Ostrander", "age": 54, "title": "CFO & Sec.", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": {"raw": 476241, "fmt": "476.24k", "longFmt": "476,241"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Ryan D. Michalek Ph.D.", "title": "Sr. VP of Operations & Strategic Devel.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Justin  Stebbing FRCP, FRCPath, M.A., M.D., Ph.D.", "title": "Chief Medical Advisor and Member of Scientific & Clinical Advisory Board", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Colonel George E. Peoples Jr., F.A.C.S., FACS, M.D.", "title": "Chief Medical Advisor", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Anthony M. Manning Ph.D.", "age": 60, "title": "Chief Scientific Advisor", "yearBorn": 1962, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Paul W. Tebbey M.B.A., Ph.D.", "title": "Sr. VP of Product Devel. & Portfolio Strategy", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}